ANDA 84772, held by Alpharma US Pharms. Promethazine Hydrochloride.
As of Nov 16, 2026, ANDA 84772 (Prometh Fortis), held by Alpharma US Pharms, was first approved by FDA on Nov 14, 1978, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 14, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prometh Fortis25MG/5ML ยท syrup;oral | Promethazine Hydrochloride | Discontinued |
| Apr 18, 1990 | Supplement 20Labeling | Approved | None posted |
| Nov 28, 1989 | Supplement 19Labeling | Approved | None posted |
| Sep 27, 1988 | Supplement 16Labeling | Approved | None posted |
| Jun 6, 1988 | Supplement 15Labeling | Approved | None posted |
| Nov 14, 1978 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters